What question did this study set out to answer?

The study aims to evaluate the effectiveness of conversion surgery after treatment with immune checkpoint inhibitors and chemotherapy for unresectable gastric cancer.

April 18, 2026World Journal of Surgery0 citations

View Full Paper

Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer

MNMasaaki NishiTokushima University YWYuma WadaTokushima University CTChie TakasuTokushima University

Key Points

The study aims to evaluate the effectiveness of conversion surgery after treatment with immune checkpoint inhibitors and chemotherapy for unresectable gastric cancer.
Analyzed cases of gastric cancer treated with immune checkpoint inhibitors and chemotherapy.
Evaluated patient eligibility for conversion surgery post-treatment.
Assessed surgical outcomes and survival rates.
Conversion surgery was performed successfully in a significant number of patients after initial treatment.
Patients showed improved survival rates compared to those who did not undergo surgery.
The approach indicates a promising strategy for managing unresectable gastric cancer.

Abstract

CS following combination treatment with ICI and chemotherapy may be promising for initially unresectable metastatic GC.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Nishi et al. (Thu,) studied this question.

synapsesocial.com/papers/69e320e740886becb654013d https://doi.org/https://doi.org/10.1002/wjs.70372

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI से पूछें

Bookmark

View Full Paper